PREDICTION OF INDIVIDUALIZED TREATMENT IN CHILDREN WITH DRUG-RESISTANT EPILEPSY BASED ON CLINICAL, GENETIC AND NEUROIMMUNOLOGICAL PREDICTORS USING ARTIFICIAL INTELLIGENCE
Keywords:
children, epilepsy, drug-resistant epilepsy, clinical predictors, genetics, neuroimmunology, artificial intelligenceAbstract
Drug-resistant epilepsy in children is one of the major challenges in modern pediatrics and neurology and is associated with recurrent epileptic seizures, impaired psychomotor and cognitive development, and reduced quality of life. Early identification of the risk of drug resistance and prediction of treatment response are important for selecting an individualized therapeutic strategy. This article discusses the potential of comprehensive assessment of clinical, genetic, and neuroimmunology characteristics of drug-resistant epilepsy in children and the application of artificial intelligence technologies to predict response to individualized treatment. Integration of clinical, genetic, immunological, electroencephalographic, and neuroimaging data is proposed to identify the risk of drug resistance and predict treatment effectiveness. This approach may contribute to improving early diagnosis and personalized treatment strategies in pediatric epilepsy.
References
1. 1. Scheffer, I. E., et al. (2017). "ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology." “Epilepsia”, 58(4), 512–521. Kwong K., Chak W.K., Kwan S.N. Epidemiology of childhood epilepsy in a cohort of 309 Chinese children // J. Pediatr Neurol. – 2001. – Vol. 24. – P. 276-282.
2. Howell, K. B., et al. (2018). "Epileptic encephalopathy: Use of genetic testing to guide treatment." // The Lancet Neurology //, 17(6), 539–550.
3. Howell, K. B., et al. (2018). "Epileptic encephalopathy: Use of genetic testing to guide treatment." // The Lancet Neurology //, 17(6), 539–550.
4. Hirsch, E., et al. (2020). "Emerging biomarkers for epileptic encephalopathy." //Brain, 143(1), 20–28.
5. Trinka, E., & Kälviäinen, R. (2017). "Epileptic encephalopathies: Bridging the gap between clinical features and mechanisms of disease." //Epilepsy & Behavior//, 69, 3–7.
6. Sadleir, L. G., & Scheffer, I. E. (2021). "Epileptic encephalopathy in infancy and early childhood." //Epilepsia, 62(6), 1237–1250.
7. Tang, S., et al. (2020). "Electroencephalographic patterns in early-onset epileptic encephalopathies." //Clinical Neurophysiology//, 131(8), 1939–1947.
8. Guerrini, R., et al. (2018). "Neuroimaging in epileptic encephalopathies.", //Pediatric Neurology, 89, 10–18.
9. Specchio, N., & Pietrafusa, N. (2022). Advances in understanding early childhood epileptic encephalopathy and its genetic underpinnings. //Brain Communications, 5(5).
10. Shields, W. D. (2020). Lennox-Gastaut syndrome: Update and innovative approaches to therapy. //Epilepsy Research, 162.
11. Hughes, J. R. (2020). Review of EEG findings in epileptic encephalopathies. //Clinical EEG and Neuroscience, 51(1).
12. Symonds, J. D. et al. (2021). Epileptic and developmental encephalopathies in childhood: Diagnostic progress and challenges. //Epilepsy Currents, 21(4).